Ceron Rhee

Ceron Rhee is Co-Founder and Managing Partner at Curewell Capital, a private equity firm focused exclusively on building industry-leading healthcare companies. Ceron brings 18 years of experience investing in and collaborating with leading healthcare organizations and management teams. Prior to founding Curewell, Ceron was an Investment Partner at Pritzker Private Capital where he helped lead the firm’s investments in the healthcare sector. Ceron previously focused on healthcare private equity at TPG Capital and The Blackstone Group, where he worked with global market leaders across healthcare services, pharmaceutical services, medical devices and technology. He currently serves on the Board of Directors of Alliance for Multispecialty Research, WeInfuse, and Wilmington PharmaTech.  

Ceron received a B.S. in Biological Sciences and a B.A. in Economics from Stanford University and an MBA from Stanford Graduate School of Business. Ceron has co-authored a number of scientific research and health economics articles. He also worked on U.S. healthcare policy supporting the White House Council of Economic Advisers. He is a member of Korea Finance Society’s Senior Advisor Network.